Focus on Throughput and Scalability
As laboratories scale operations, the Cell Lysis and Disruption Market is responding with solutions that handle larger sample volumes and higher throughput.
High-pressure homogenizers capable of processing liters of culture in minutes, or automated platforms that manage hundreds of samples in parallel, are becoming essential in industrial biotech and biopharma manufacturing. Scalability is now a critical purchasing criterion for many institutions seeking to future-proof their workflows.
1 View